Trump to Announce New Drug Price Agreements with Around 10 Pharmaceutical Companies

President Trump is expected to announce new drug price agreements with around 10 pharmaceutical companies, according to reports. The move extends the administration's policy of tying U.S. drug prices to lower international rates. CNBC reported on October 31 (local time) that the Trump administration is preparing to unveil these agreements with pharmaceutical firms. Reuters cited a White House official, stating President Trump is anticipated to make the announcement on October 31. The White House event aimed at reducing healthcare costs will take place at 3 p.m. EDT on October 31, corresponding to 4 a.m. KST on November 1.
Financial Times reported that Bayer, Takeda, and CSL, along with some mid-sized biotech companies, are expected to participate in the announcement. The agreements align with the ongoing most-favored-nation pricing policy initiated last year. Reuters previously noted that 17 major pharmaceutical companies, including Pfizer, Eli Lilly, and Amgen, had already agreed to lower prices for federal healthcare programs and direct sales.
Korean Source
This article is an English localization of a Korean-language crypto news report. Original headline: 트럼프, 제약사 10곳 안팎 약가 계약 예고